NCT04507412View on ClinicalTrials.gov

Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty

PHASE4RecruitingINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

July 31, 2032

Study Completion Date

August 31, 2032

Conditions

Arthroplasty, Replacement, Shoulder

Interventions

DRUG

dexamethasone

perioperatively 9 mg i.v subministration

Trial Locations (1)

6900

RECRUITING

Christian Candrian, Lugano

All Listed Sponsors

lead

Christian Candrian

OTHER